RCCX

RCCX is a complex, multiallelic, and tandem copy number variation (CNV) human DNA locus on chromosome 6p21.3, located in the major histocompatibility complex (MHC) class III region.[1][2] CNVs are segments of DNA that vary in copy number compared to a reference genome and play a significant role in human phenotypic variation and disease development. The RCCX module consists of a series of genes close to each other: serine/threonine kinase 19 (STK19), complement 4 (C4), steroid 21-hydroxylase (CYP21), and tenascin-X (TNX).[3]

Name

The RCCX abbreviation composed of the names of the genes RP (a former name for STK19 serine/threonine kinase 19),[2][3] C4, CYP21 and TNX).[4]

Structure

The number of RCCX segments varies between one and four in a chromosome,[2] with the prevalence of approximately 15% for monomodular, 75% for bimodular (STK19-C4A-CYP21A1P-TNXA-STK19B-C4B-CYP21A2-TNXB),[3] and 10% for trimodular in Europeans.[5] The quadrimodular structure of the RCCX unit is very rare.[6][2][5]

In a monomodular structure, all of the genes are functional i.e. protein-coding, but if a module count is two or more, there is only one copy of each functional gene rest being non-coding pseudogenes with the exception of the C4 gene which always has active copies.[2][5] Each copy of the C4 gene, due to five adjacent nucleotide substitutions cause four amino acid changes and immunological subfunctionalization,[5] can be of one of two types: C4A and C4B.[7] Each C4 gene contains 41 exons and has a dichotomous size variation between approximately 22 kb and 16 kb, with the longer variant being the result of the integration of the endogenous retrovirus HERV-K(C4) into intron 9.[3]

The RCCX module is the most complex gene cluster in the human genome.[3][7][8] It is part of the major histocompatibility complex (MHC) class III (MHC class III),[9][10] which is the most gene-dense region of the human genome, containing many genes that yet have unknown function or structure.[11][12][13][14] RCCX modules exhibit a high degree of linkage disequilibrium, meaning that genes are inherited together. This makes the RCCX module well suited for genetic association studies, especially in the context of autoimmune diseases.

Function

The RCCX module is involved in the synthesis of the steroid hormones cortisol, aldosterone, and androgen precursors, in extracellular matrix glycoprotein synthesis, and in innate immune system.

The RP gene (a former name for the STK19 gene) is involved in cell growth and differentiation, but its exact functions remain unclear.[15]

The C4 gene encodes the complement component 4, which is involved in the complement system and is an important part of the innate immune system. The gene has two forms: C4A and C4B, encoding form A and B of the complement component 4 protein, respectively.

The CYP21A2 gene encodes the enzyme 21-hydroxylase involved in synthesizing cortisol and aldosterone.

The TNXB gene encodes the Tenascin X, an extracellular matrix glycoprotein. Tenascin X is involved in the formation and maintenance of the extracellular matrix, which provides structural support and regulates cell behavior. It is also involved in tissue repair and regeneration and musculoskeletal development. Tenascin X interacts with other extracellular matrix proteins such as fibrillin-1 and collagen and is thought to play a role in regulating their organization and function.

Clinical significance

The RCCX module is related to personality traits such as novelty seeking and impulsivity[16] as major histocompatibility complex (MHC), where the RCCX module is located, may affect these traits through its role in immune function and neurodevelopment, still, the exact mechanisms are not fully understood.[3]

Variations in complement component C4 genes within the RCCX module have been associated with psychiatric disorders such as schizophrenia and neurodegenerative diseases like Alzheimer's disease.[3]

The RCCX module may be involved in developing autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis. The C4A gene may be associated with an increased risk of systemic lupus erythematosus, while the C4B gene may be associated with an increased risk of rheumatoid arthritis.[17][18][19] The presence of multiple RCCX modules is also associated with an increased risk of autoimmune diseases.[3]

Genetic variations in the RCCX module have been linked to many other disorders, including autism spectrum disorder, and drug addiction.[20]

The CYP21 gene is associated with developing congenital adrenal hyperplasia due to 21-hydroxylase deficiency, a genetic disorder that affects the adrenal glands and causes cortisol deficiencies (that may lead to virilization of female infants) and in severe cases also aldosterone deficiencies (that may lead to salt wasting - large amounts of sodium in urine that causes such life-threating consequences as hypotension, hyponatremia, and hyperkalemic metabolic acidosis).[21]

The TNX gene, also known as tenascin-X, is is associated with such disorders of connective tissue, such as the Ehlers-Danlos syndrome (EDS), characterized by joint hypermobility, skin hyperextensibility, and tissue fragility. Another disorder, when recombination events occur between TNXA and TNXB genes within the RCCX module, resulting in CYP21A2 deletion along with impaired TNXB function, is called CAH-X Syndrome and leads to both CAH symptoms and features consistent with EDS.[3] The exact molecular mechanisms through which alterations or deficiencies in the TNX gene lead to these conditions are not fully understood yet but are believed to be related to defects in extracellular matrix organization and cell adhesion processes mediated by tenascin-X protein.[3]

References

  1. Chang SF, Lee HH (2011). "Analysis of the CYP21A2 gene with intergenic recombination and multiple gene deletions in the RCCX module". Genet Test Mol Biomarkers. 15 (1–2): 35–42. doi:10.1089/gtmb.2010.0080. PMID 21117955.
  2. Bánlaki Z, Doleschall M, Rajczy K, Fust G, Szilágyi A (October 2012). "Fine-tuned characterization of RCCX copy number variants and their relationship with extended MHC haplotypes". Genes Immun. 13 (7): 530–5. doi:10.1038/gene.2012.29. PMID 22785613. S2CID 36582994.
  3. Carrozza C, Foca L, De Paolis E, Concolino P (2021). "Genes and Pseudogenes: Complexity of the RCCX Locus and Disease". Front Endocrinol (Lausanne). 12: 709758. doi:10.3389/fendo.2021.709758. PMC 8362596. PMID 34394006.
  4. Sweeten TL, Odell DW, Odell JD, Torres AR (January 2008). "C4B null alleles are not associated with genetic polymorphisms in the adjacent gene CYP21A2 in autism". BMC Medical Genetics. 9: 1. doi:10.1186/1471-2350-9-1. PMC 2265260. PMID 18179706.
  5. Bánlaki Z, Szabó JA, Szilágyi Á, Patócs A, Prohászka Z, Füst G, Doleschall M (2013). "Intraspecific evolution of human RCCX copy number variation traced by haplotypes of the CYP21A2 gene". Genome Biol Evol. 5 (1): 98–112. doi:10.1093/gbe/evs121. PMC 3595039. PMID 23241443.
  6. Tsai LP, Lee HH (September 2012). "Analysis of CYP21A1P and the duplicated CYP21A2 genes". Gene. 506 (1): 261–2. doi:10.1016/j.gene.2012.06.045. PMID 22771554.
  7. Doleschall M, Luczay A, Koncz K, Hadzsiev K, Erhardt É, Szilágyi Á, Doleschall Z, Németh K, Török D, Prohászka Z, Gereben B, Fekete G, Gláz E, Igaz P, Korbonits M, Tóth M, Rácz K, Patócs A (June 2017). "A unique haplotype of RCCX copy number variation: from the clinics of congenital adrenal hyperplasia to evolutionary genetics". Eur J Hum Genet. 25 (6): 702–710. doi:10.1038/ejhg.2017.38. PMC 5477366. PMID 28401898.
  8. Milner CM, Campbell RD (August 2001). "Genetic organization of the human MHC class III region". Frontiers in Bioscience: A Journal and Virtual Library. 6: D914–26. doi:10.2741/milner. PMID 11487476.
  9. Yu CY (1998). "Molecular genetics of the human MHC complement gene cluster". Exp Clin Immunogenet. 15 (4): 213–30. doi:10.1159/000019075. PMID 10072631. S2CID 25061446.
  10. Yu CY, Chung EK, Yang Y, Blanchong CA, Jacobsen N, Saxena K, Yang Z, Miller W, Varga L, Fust G (2003). "Dancing with complement C4 and the RP-C4-CYP21-TNX (RCCX) modules of the major histocompatibility complex". Prog Nucleic Acid Res Mol Biol. Progress in Nucleic Acid Research and Molecular Biology. 75: 217–92. doi:10.1016/s0079-6603(03)75007-7. ISBN 9780125400756. PMID 14604014.
  11. Xie T, Rowen L, Aguado B, Ahearn ME, Madan A, Qin S, Campbell RD, Hood L (December 2003). "Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse". Genome Research. 13 (12): 2621–36. doi:10.1101/gr.1736803. PMC 403804. PMID 14656967.
  12. Rupert KL, Rennebohm RM, Yu CY (1999). "An unequal crossover between the RCCX modules of the human MHC leading to the presence of a CYP21B gene and a tenascin TNXB/TNXA-RP2 recombinant between C4A and C4B genes in a patient with juvenile rheumatoid arthritis". Exp Clin Immunogenet. 16 (2): 81–97. doi:10.1159/000019099. PMID 10343159. S2CID 24623016.
  13. Espinosa Reyes TM, Collazo Mesa T, Lantigua Cruz PA, Agramonte Machado A, Domínguez Alonso E, Falhammar H (November 2020). "Molecular diagnosis of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency". BMC Endocrine Disorders. 20 (1): 165. doi:10.1186/s12902-020-00643-z. PMC 7653887. PMID 33168061.
  14. Lee HH (January 2005). "Chimeric CYP21P/CYP21 and TNXA/TNXB genes in the RCCX module". Mol Genet Metab. 84 (1): 4–8. doi:10.1016/j.ymgme.2004.09.009. PMID 15639189.
  15. Asquith CRM, Temme L (September 2020). "STK19: a new target for NRAS-driven cancer". Nat Rev Drug Discov. 19 (9): 579. doi:10.1038/d41573-020-00116-x. PMID 32587355. S2CID 256745367.
  16. Piero Portincasa, Gema Frühbeck, Hendrik M. Nathoe, ed. (2019). "Endocrine Disorders and Psychiatric Manifestations". Endocrinology and Systemic Diseases. Springer Cham. pp. 1–35. doi:10.1007/978-3-319-66362-3_12-1. ISBN 978-3-319-66362-3. S2CID 164396406.{{cite book}}: CS1 maint: multiple names: editors list (link)
  17. Wu Z, Zhang S, Li P, Zhang F, Li Y (November 2020). "Association between complement 4 copy number variation and systemic lupus erythematosus: a meta-analysis". Clin Exp Med. 20 (4): 627–634. doi:10.1007/s10238-020-00640-5. PMID 32691186.
  18. Pereira K, Perazzio S, Faria A, Moreira ES, Santos VC, Grecco M, da Silva NP, Andrade L (August 2019). "Impact of C4, C4A and C4B gene copy number variation in the susceptibility, phenotype and progression of systemic lupus erythematosus". Adv Rheumatol. 59 (1): 36. doi:10.1186/s42358-019-0076-6. PMID 31387635. {{cite journal}}: Vancouver style error: initials in name 1 (help)
  19. "Low Gene Copy Number for C4, C4A and C4B Is a Strong Risk Factor for Developing Systemic Lupus Erythematosus in Childhood".
  20. Trowsdale J, Knight JC (2013). "Major histocompatibility complex genomics and human disease". Annu Rev Genomics Hum Genet. 14: 301–23. doi:10.1146/annurev-genom-091212-153455. PMC 4426292. PMID 23875801.
  21. Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJ, Gripp KW, Amemiya A, Nimkarn S, Gangishetti PK, Yau M, New MI (1993). "21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia". PMID 20301350. {{cite journal}}: Cite journal requires |journal= (help)


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.